GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $9.20 million. The enterprise value is $7.89 million.
| Market Cap | 9.20M |
| Enterprise Value | 7.89M |
Important Dates
The next estimated earnings date is Friday, August 2, 2024, before market open.
| Earnings Date | Aug 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 5.48 million shares outstanding. The number of shares has increased by 60.99% in one year.
| Shares Outstanding | 5.48M |
| Shares Change (YoY) | +60.99% |
| Shares Change (QoQ) | +8.79% |
| Owned by Insiders (%) | 34.61% |
| Owned by Institutions (%) | 2.86% |
| Float | 3.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 24.48 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.31 |
| Quick Ratio | n/a |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 253.08 |
Financial Efficiency
Return on equity (ROE) is -179.30% and return on invested capital (ROIC) is -1,329.80%.
| Return on Equity (ROE) | -179.30% |
| Return on Assets (ROA) | -130.50% |
| Return on Capital (ROIC) | -1,329.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.26M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.10% in the last 52 weeks. The beta is 0.13, so GlucoTrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -2.10% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 1.63 |
| Relative Strength Index (RSI) | 31.64 |
| Average Volume (20 Days) | 10,679 |
Short Selling Information
The latest short interest is 17,329, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 17,329 |
| Short Previous Month | 16,541 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.58% |
| Short Ratio (days to cover) | 0.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.59M |
| Pretax Income | -7.56M |
| Net Income | -7.56M |
| EBITDA | -7.58M |
| EBIT | -7.59M |
| Earnings Per Share (EPS) | -$2.05 |
Balance Sheet
The company has $1.51 million in cash and $195,000 in debt, giving a net cash position of $1.31 million or $0.24 per share.
| Cash & Cash Equivalents | 1.51M |
| Total Debt | 195,000 |
| Net Cash | 1.31M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 376,000 |
| Book Value Per Share | 0.07 |
| Working Capital | 455,000 |
Cash Flow
In the last 12 months, operating cash flow was -$8.19 million and capital expenditures -$59,000, giving a free cash flow of -$8.25 million.
| Operating Cash Flow | -8.19M |
| Capital Expenditures | -59,000 |
| Free Cash Flow | -8.25M |
| FCF Per Share | -$1.65 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GlucoTrack does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.99% |
| Shareholder Yield | -60.99% |
| Earnings Yield | -82.17% |
| FCF Yield | -89.59% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 20, 2024. It was a reverse split with a ratio of 1:5.
| Last Split Date | May 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |